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One of the in￿ ammatory responses of the eye to
local application of platelet-activating factor (PAF)
is oedema of the conjunctiva, caused by extrava-
sation of plasma. Aim of the study was to investi-
gate if ￿ uorescein would leak from the blood into
the tears together with plasma protein after
application of PAF to the eye. Fluorescein was
given intraperitoneally 30min prior to applica-
tion of 25 ml of 0.1% solution of PAF. Thirty min
after PAF the tear ￿ lm was collected by washing
the surface of the eye with 25 ml of phosphate
buffered saline (PBS). Fluorescein in eye washings
and in plasma was measured by ￿ uorophoto-
metry and albumin by immunodiffusion. Both
￿ uorescein and albumin appeared in a related
fashion in tears, being absent in washings of
placebo-treated control eyes. Extravasation of
￿ uorescein can be used as a measure for plasma
leakage in the conjunctiva with the advantage
over the Evans Blue method that the former is a
non-invasive method.
Key words: Platelet-activatingfactor(PAF),Fluorescein,
Albumin, Guinea pig, Blood±tear barrier
Introduction
The blood±tear barrier, causing the large con-
centration differences between tear and blood
components, is formed by the acinar and ductal
cells of the lacrimal gland and by the conjuncti-
val and corneal epithelium at the surface of the
eye.
Breakdown of the blood±tear barrier occurs
in allergic conjunctivitis, where increased vascu-
lar permeability has been described as an
important feature.1 Besides histamine and pros-
taglandins, platelet activating factor (PAF) takes
part in the in￿ammatory process.2 On a molar
basis PAF appeared to be 103 to 104 times more
potent in inducing vascular permeability
changes in skin compared with histamine.3 In
guinea pigs topical application of PAF on the
eye produces within 30 min a dose-dependent
increase of the vascular permeability of the
conjunctiva, as determined by measurement of
the serum albumin concentration in lavage ￿uid
of the surface of the eye.1
The aim of the present study is to investigate
if application of PAF to the eye might also cause
leakage of intraperitoneal injected ￿uorescein
from blood into the tears together with serum
albumin. Both ￿uorescein and albumin ap-
peared signi￿cantly correlated in the eye wash-
ings after application of PAF .
Materials and Methods
Eight female Hartley strain guinea pigs (weight
range 350±450 g) were intraperitoneally in-
jected with 0.25ml/kg body weight of a 20%
solution of ￿uorescein sodium and 30 min later
25 ml of 0.1% solution of PAF in phosphate
buffered saline (PBS) was applied to the right
eyes. The left eyes served as controls and
received 25 ml of PBS.
Thirty min after application of PAF or PBS
tears were collected by washing the surface of
the eye with 25 ml of PBS, using a polypropy-
lene micropipette, avoiding touching the eye.
After three forced blinks the lavage ￿uid was
collected and stored at - 208 C until use. Blood
was collected by heart puncture of the animals,
anticoagulated with heparin and centrifuged for
separation of the plasma.
Albumin concentration in lavage ￿uid was
determined using a radial immunodiffusion
method in agar plates (1.5% ), containing guinea
pig albumin antiserum in 1:100 dilution. Various
concentrations of guinea pig albumin were used
as standard. Samples (5 ml) were tested in
appropriate dilutions.
Fluorescein was measured in lavage ￿uid and
plasma by ￿uorophotometry, using a ￿uoro-
photometer (Fluorotron Master, Ocumetrics
Inc., Mountain View, CA, USA). For measure-
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of PBS in a 5 mm-cuvette and plasma 20 ml was
diluted in 4 ml of PBS in a 10 mm-cuvette.
Fluorescence was measured in the range 510±
600 nm, using an excitation wavelength of
430±490 nm.
PAF was purchased from Cayman (Ann Arbor,
MI, USA), guinea-pig albumin antiserum and
guinea-pig albumin from Nordic (Tilburg, The
Netherlands). Animals were housed and cared
in accordance with rules and regulations of the
European Community Board concerning the use
of experimental animals (86/609/CEE).
Results
Fig. 1 shows a signi￿cant correlation of the
￿uorescein concentration, expressed in percent-
age of the plasma concentration, and the
albumin concentration in the lavage ￿uid of
eyes, treated with PAF , in eight animals. The
concentrations of ￿uorescein and albumin in
lavage ￿uid of PBS treated eyes were below the
detection limit of respectively 3 ng/ml and
15 mg/ml. The measured concentrations of
￿uorescein in plasma varied from 11.2 to
25.0mg/ml (mean 16·3 1·7) and in lavage
￿uid from 3 to 257 ng/ml (mean 147·5 38).
Albumin concentrations varied from 0 to
376 mg/ml (mean 188 48).
Discussion
The variation of the appearance of albumin in
the lavage ￿uid of the eyes in response to local
application of PAF is in correspondence with
our observations, described earlier.1 The great
variation in response may be explained by
variation in the penetration of the outer eye.
The resorption depends on the ocular contact
time of the eye drop, containing PAF , and on
enzymatic hydrolysis of PAF to lyso-PAF by an
acetylhydrolase, present in ocular tissue.4 Sev-
eral ocular tissues themselves, subsequent to
in￿ammation, are able to produce PAF in ng
quantities.5
Albumin is not produced by the lacrimal
gland of the guinea pig6 and the appearance of
albumin on the ocular surface is a result of the
￿ow of plasma protein containing tissue ￿uid
across the epithelium to the ocular surface
under the in￿uence of PAF . The lavage ￿uid
from the surface of the eye at this stage
contains a mixture of leaking plasma and
lacrimal gland ￿uid from the lacrimal gland.
The amount of ￿uorescein leaking out of
the blood vessels is dependent on the rapidly
changing concentration of ￿uorescein in the
blood. Therefore ￿uorescein concentrations
are calculated as percentage of the plasma
concentration. The same should apply for
serum albumin, however the plasma concen-
tration of about 45 g/l is not likely to change
in short-time experiments as carried out in
this study. The greater part, more than 90%of
￿uorescein in blood is bound to protein and
this explains the relationship in lavage ￿uid
found for albumin and ￿uorescein. The deter-
mination of albumin in lavage ￿uid as a
measure for conjunctival in￿ammation is a
relatively simple method.
The Evans Blue method for measuring extra-
vasation of plasma in in￿amed conjunctival
tissue is based on the same principle of co-
migration of dye with plasma proteins. However
it is an invasive procedure where the animals
have to be killed for isolation of the conjuncti-
val tissue and extraction of extravasated dye.
The concentration of Evans Blue in the tears is
too low to be detectable by colorimetry com-
pared with ￿uorescein, which can be measured
￿uorimetrically with a detection limit of
1 ng/ml. Measurement of ￿uorescein in lavage
￿uid of the eyes is an alternative for Evans Blue
with the advantage that it is not necessary to
kill the animals.
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FIG. 1. Relationship between albumin and ¯ uorescein in
lavage ¯ uid of eyes of guinea pigs, collected 30 min after
treatment with 25 ml of 0.1% PAF. Correlation coef® cient
0.98 (P , 0.0001, n= 8).
382 Mediators of In¯ ammation ´ Vol 6 ´ 1997
J. L. van Delft et al.4. Bazan HEP, Tao Y, Hurst JS. Platelet-activating factor antagonists and
ocular in￿ammation. J Ocul Pharm acol 1994; 10: 319±327.
5. Rosenbaum JT , Boney RS, Samples JR, Valone FH. Synthesis of platelet
activating factor by ocular tissue from in￿amed eyes. Arch Ophth almol
1991; 109: 410±413.
6. Tho ¨rig L, van Agtmaal EJ, Glasius E, Tan KL, van Haeringen NJ.
Comparison of tears and lacrimal gland ￿uid in the rabbit and guinea
pig. Curr Eye Res 1985; 4: 913±920.
Received 15 May 1997;
accepted in revised form 12 June 1997
Mediators of In¯ ammation ´ Vol 6 ´ 1997 383
Effect of PAF on the blood–tear barrier